Queset Medical Offers Filters for Safe Spirometry Including all ndd Models and Midmark and Welch-Allyn Models

Queset Medical, Inc., is a leading distributor of supplies for pulmonary function testing offering a complete line of PFT Anti-Viral filters that comply with recent guidance for spirometry testing during the Corona Virus pandemic.

Queset Medical notes their Anti-Viral Filters meet the recommendations published in reports from the American Thoracic Society, The European Respiratory Society and Canadian Respiratory Society. High-efficiency filters are available for all spirometers including all models of ndd, Midmark, and Welch-Allyn devices.

All filters are FDA approved and provide over 99.99% cross-contamination efficiency for virus control.

Our filtered mouthpieces protect both the patient as well as the test environment. Some spirometers use mouthpieces that are nothing more than hollow tubes. During a spirometry test, the patient is told to exhale as forcefully as possible. This can lead to pathogens being blown around the test environment and onto anyone in the vicinity. Queset’s high-efficiency filters capture these pathogens before they can spread.

Michael J. Boyle, President of SDI Diagnostics, Inc., the manufacturer of the filters, comments that “All filters have been tested and are certified to have passed all requirements of the American Thoracic Society.” He added “they are totally compliant with recent guidelines that state ‘Tests should always be carried out with a high specification disposable in-line bacterial and viral filter in place (We recommend filters with minimum proven efficiency for high expiratory flow of 600 to 700 L/min). Use of disposable combined mouthpieces/sensors is not recommended at this time.’”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version